LXRepair 2013-2023 Alternatives & Competitors

12 companies similar to LXRepair 2013-2023 — 2013-2023

On-Q-ity

Empowering physicians with advanced tools to improve cancer treatment decisions and enhanc...

Series B $31.00M

Biotechnology Health Care

CCG.ai (acquired by Dante Labs)

Data-Driven Cancer Treatment. CCG.ai

2 Seed $8.50M

Cambridge, United Kingdom

Biotechnology Health Care

Sensius

Balanced Treatment

13 Venture round $12.67M

Rotterdam, The Netherland...

Biotechnology Health Care +1

Calmark Sweden AB

Caring for a calm start

4 Venture round

Sweden

Biotechnology Health Care

Track all LXRepair 2013-2023 competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Viewpoint Molecular Targeting, Inc.

Targeted α-Particle Radiotherapy for Cancer

10 Grant $27.26M

Coralville, United States

Biotechnology Health Care +2

MiraDx

Tailoring cancer treatment based on your patient’s unique response and toxicity profile.

28 Series A $4.00M

Los Angeles, United State...

Biotechnology Health Care

Compare

German Oncology Center

Compassion drives innovation

164

Cyprus

Health Care Health and Wellness

Convergent RnR Ltd.

A NEW APPROACH TO ONCOLOGY RADIOTHERAPY

18 Venture round $1.20M

Israel

Biotechnology Health Care

Oxford Cancer Biomarkers

Pioneering Precision Medicine

7 Grant $1.48M

Biopharma Biotechnology +1

GeneCast Biotechnology Co., Ltd.

21 Series E $351.00M

Beijing, China

Biotechnology Health Care

ViewRay, Inc.

Conquer cancer by re-envisioning radiation therapy.

76 Post-IPO Debt $462.49M

United States

Biotechnology Health Care +2

OncoDNA

Genomic and theranostic company specializing in precision medicine for the treatment of ca...

52 Series C $35.38M

Belgium

Biotechnology Health Care

About LXRepair 2013-2023

LXRepair 2013-2023 LXRepair 2013-2023 has focused on providing decision aids to oncologists in the challenging landscape of cancer treatment. They emphasize the significance of profiling in predicting treatment toxicity and efficacy on tumors, leveraging over a decade of research by the French Atomic Energy Commission...

Business keywords

Diagnostics, Biomarkers, DNA Repair, Medtech, DNA Signature, Innovation, Clinical Studies, Cancer Treatment, Predictive Medicine, R&D, Investment, Radiotoxicity, Radiotherapy, Chemotherapy

Frequently Asked Questions

Companies similar to LXRepair 2013-2023 include On-Q-ity, CCG.ai (acquired by Dante Labs), Sensius, Calmark Sweden AB, Viewpoint Molecular Targeting, Inc.. They work in Biotechnology and Health Care and share LXRepair 2013-2023's focus on cancer treatment, radiotherapy and chemotherapy.

Bounce Watch lists 12 companies that share LXRepair 2013-2023's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches LXRepair 2013-2023 and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

LXRepair 2013-2023 Profile On-Q-ity Alternatives Sensius Alternatives Calmark Sweden AB Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at LXRepair 2013-2023 on 11 Jun 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 11 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.